Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 136,280 | 201,830 | 310,871 | 235,976 | 81,186 |
| Receivables | 1,020,784 | 851,368 | 895,613 | 886,491 | 809,229 |
| Inventories | 677,954 | 641,618 | 606,302 | 614,500 | 608,973 |
| TOTAL | $1,947,029 | $1,797,907 | $1,911,181 | $1,838,478 | $1,584,692 |
| Non-Current Assets | |||||
| PPE Net | 456,877 | 444,607 | 442,950 | 434,991 | 440,327 |
| Intangibles | 1,181,329 | 1,128,669 | 1,158,968 | 1,183,883 | 1,246,953 |
| Other Non-Current Assets | 191,113 | 169,035 | 165,181 | 142,522 | 150,816 |
| TOTAL | $1,829,319 | $1,742,311 | $1,767,099 | $1,761,396 | $1,838,096 |
| Total Assets | $3,776,348 | $3,540,218 | $3,678,280 | $3,599,874 | $3,422,788 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 105,961 | 6,200 | 6,761 | 7,202 | 321,175 |
| Accounts payable and accrued liabilities | 743,278 | 696,014 | 816,801 | 800,037 | 730,213 |
| Other current liabilities | 18,488 | 10,550 | 43,256 | 40,598 | 41,515 |
| TOTAL | $883,187 | $728,049 | $881,633 | $862,106 | $1,107,134 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,564,335 | 2,565,558 | 2,565,115 | 2,566,500 | 2,146,403 |
| Other Non-Current Liabilities | 283,850 | 221,960 | 288,364 | 265,460 | 268,591 |
| TOTAL | $2,860,137 | $2,858,138 | $2,867,976 | $2,847,723 | $2,428,187 |
| Total Liabilities | $3,743,324 | $3,586,187 | $3,749,609 | $3,709,829 | $3,535,321 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 319,354 | 319,023 | 314,629 | 314,363 | 314,079 |
| Common Shares | 3,193 | 3,190 | 3,146 | 3,143 | 3,140 |
| Retained earnings | -415,087 | -472,749 | -535,005 | -570,081 | -572,450 |
| Other shareholders' equity | -100,666 | -112,709 | -111,264 | -106,380 | -97,846 |
| TOTAL | $33,024 | $-45,969 | $-71,329 | $-109,955 | $-112,533 |
| Total Liabilities And Equity | $3,776,348 | $3,540,218 | $3,678,280 | $3,599,874 | $3,422,788 |